|
C12ORF49 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.779900E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.136400E-02 |
| Normal-vs-Stage2 |
4.484400E-01 |
| Normal-vs-Stage3 |
7.442800E-01 |
| Normal-vs-Stage4 |
5.154800E-04 |
| Stage1-vs-Stage2 |
6.669000E-01 |
| Stage1-vs-Stage3 |
4.146200E-01 |
| Stage1-vs-Stage4 |
1.355390E-01 |
| Stage2-vs-Stage3 |
8.047200E-01 |
| Stage2-vs-Stage4 |
1.793240E-01 |
| Stage3-vs-Stage4 |
9.683600E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.412960E-01 |
| Normal-vs-AfricanAmerican |
3.897000E-01 |
| Normal-vs-Asian |
3.431600E-04 |
| Caucasian-vs-AfricanAmerican |
7.921600E-01 |
| Caucasian-vs-Asian |
3.051800E-01 |
| AfricanAmerican-vs-Asian |
1.586400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.575100E-03 |
| Normal-vs-Female |
2.406000E-01 |
| Male-vs-Female |
2.958300E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.866990E-01 |
| Normal-vs-Extreme_Weight |
3.551200E-04 |
| Normal-vs-Obese |
3.128000E-01 |
| Normal-vs-Extreme_Obese |
2.805200E-01 |
| Normal_Weight-vs-Extreme_Weight |
2.400000E-01 |
| Normal_Weight-vs-Obese |
6.523200E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.530000E-01 |
| Extreme_Weight-vs-Obese |
5.738100E-02 |
| Extreme_Weight-vs-Extreme_Obese |
6.189400E-01 |
| Obese-vs-Extreme_Obese |
6.258600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.157400E-01 |
| Normal-vs-Age(41-60Yrs) |
6.259000E-01 |
| Normal-vs-Age(61-80Yrs) |
1.122370E-02 |
| Normal-vs-Age(81-100Yrs) |
3.560300E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.474000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.546200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.403400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.672240E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.147630E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.574350E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.681690E-03 |
| Normal-VS-Type2 PRCC |
9.122200E-01 |
| Normal-VS-KIRP CIMP |
4.333200E-01 |
| Normal-VS-Unclassified PRCC |
2.348200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.718000E-02 |
| Type1 PRCC-VS-KIRP CIMP |
8.094600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.460400E-02 |
| Type2 PRCC-VS-KIRP CIMP |
5.287400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.386600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.475210E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.366000E-01 |
| Normal-vs-N1 |
5.213200E-01 |
| Normal-vs-N2 |
2.945400E-01 |
| N0-vs-N1 |
7.672400E-01 |
| N0-vs-N2 |
6.250400E-01 |
| N1-vs-N2 |
5.654600E-01 |
|
|
